ecancermedicalscience

Clinical Study

Diagnostic and therapeutic update of mantle cell lymphoma (MCL): analysis of seven cases treated in a centre in one year

17 Mar 2016
Carmen Herrero-Vicent, Isidro Machado, Carmen Illueca, Amparo Avaria, Claudia Salazar, Abraham Hernandez, Sergio Sandiego, Javier Lavernia

Mantle cell lymphoma (MCL) is an infrequent subtype of non-Hodgkin’s lymphoma (NHL) and represents between 4–8% of adult lymphomas. Recently an increase in its incidence to 1–2 cases/100,000 inhabitants/year has been observed. The first line of treatment is based on chemoimmunotherapy and depends on age and the initial stage at diagnosis. There are no second line or successive treatments. There are currently several drugs available that provide acceptable results.

Article metrics: 4786 views
1127
3659

Artículos relacionados

Guillermo Martín-Sánchez, Emilia Pardal de la Mano, Rosa López López, M Angeles Fernández Galán, Sergio Trinidad Ríos, M José Morán Jiménez, J María García Ruiz de Morales, M Antonia Crespo Santos, Guillermo Martín Núñez
Francisco Acevedo, Sebastián Mondaca, Valentina Hornig, Pablo Munoz-Schuffenegger, Marcelo Garrido, Bruno Nervi
Sara Tato-Varela, Rosa Albalat-Fernández, Sara Pabón-Fernández, Enrique Rodríguez Zarco, Manolo La Calle-Marcos